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Small lymphocytes circulate in blood and lymph and form the major cellular 
constituents of lymphoid tissues. These cells have a unique route of circulation 
in  the  body.  Large  numbers  of  small  lymphocytes,  entering  the  blood  via 
lymphatics,  selectively  emigrate from  the  blood  stream  in  lymphoid  tissues 
where  they  are  aggregated  and  subsequently  released  into  the  lymph  (1-7). 
The properties of lymphocytes which  control  their  traffic and  distribution  in 
the body are poorly understood. It is known that lymphocytes killed by heat or 
ultraviolet  radiation  do  not  recirculate  from blood  to  lymph  (2).  Also,  it  is 
known that the selective emigration of lymphocytes from blood into lymphoid 
tissues and their recirculation to the lymph does not require that the lympho- 
cytes be genetically identical with the host  (1-5, 8).  Furthermore, it has been 
reported  that  treatment  of  lymphocytes  in  vitro  with  a  crude  glycosidase 
preparation  (8)  or with  trypsin  (9)  prior  to intravenous  transfusion prevents 
the  cells from circulating  normally,  though  the  lymphocytes appeared  to  be 
viable at the  time they were transfused.  These latter findings  suggested  that 
structures at the surface of lymphocytes might play a  role in determining the 
distribution  of these cells.  It was,  therefore,  of interest  to determine the fate 
of lymphocytes in vivo after they had been incubated with neuraminidase,  a 
glycosidase which cleaves terminal sialic acid from heterosaccharides or glyco- 
proteins (10)  and which is known to be capable of releasing sialic acid from cell 
surfaces  (11-14).  The present report describes such studies  and provides evi- 
dence  that  treatment  of lymphocytes with neuraminidase in vitro drastically 
alters the fate and distribution  of the cells when they are subsequently trans- 
fused intravenously into recipients. 
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Materials and Methods 
Animals.--Sprague-Dawley  rats,  a  closed but not inbred stock, were used as donors and 
recipients unless otherwise indicated. In some experiments, Fisher rats, members of a highly 
inbred strain, were used. All donors and recipients were males and weighed 250-300 g. 
Reagent~.--Neuraminidase, derived from Vibrlo cholerae and prepared to contain 500 units/ 
ml, was obtained from General Biochemicals (Chagrin Falls, Ohio) and used in each experi- 
ment except where indicated. Another neuraminidase preparation  (Behringwerke Ag.,  Mar- 
burg-Lahn,  West  Germany,  and  Hoechst  Pharmaceutical  Co.,  Inc.,  Cincinnati,  Ohio)  was 
used for comparison in several experiments; this preparation, described by the manufacturer 
as having no detectable proteinase, aldolase, or lecithinase C  activity, was also derived from 
Vibrio cholerae and prepared to contain 500 units/ml. One unit of neuraminidase activity is 
defined by both manufacturers as being equivalent to the release of 1/~g of N-acetyl neuraminic 
acid from orosomucoid at 37°C in 15 rain at pH 5.5. Sialic acid, i.e. N-acetyl neuraminic acid, 
was obtained from General Biochemicals; heparin sodium from Fisher Scientific Co., Pitts- 
burgh, Pa.; and tissue culture medium 199  (M 199)  from Grand Island Biological Co., Grand 
Island, N.Y. ~lCr was purchased from Iso-Serve, Cambridge, Mass., and supplied as Na2-51Cr-O4 
in isotonic saline at  pH  7.0 with no preservative added; the specific activity varied from 100. 
200/zc/#g of chromium. Reagents used in determination of electrophoretic mobility (15)  and 
of free sialic acid  (16)  were prepared as described elsewhere. 
Collection of Lymph.--The main lymphatic duct of a donor rat was cannulated below the 
diaphragm by usual techniques (17, 2). After surgery, the unanesthetized animal was kept in a 
Bollman cage (18)  with free access to commercial rat cake and 5% dextrose in saline. Lymph 
was collected at room temperature in 125 ml flasks containing 10-15 ml of isotonic saline and 
20 units of heparin/ml. The cells for injection were obtained during an 8-12 hr period after 
free flow had been established. All collection periods were completed within the first 24 hr after 
cannulation. The collections used for experiments contained 350-500 X  l0 s lymphocytes and 
only few erythroeytes; 90-95% of the lymphocytes obtained were typical "small" lymphocytes. 
Radioactive Labeling of Lymphocytes.--Lymphoeytes  were  separated  from  tile lymph  by 
centrifugation at 4°C for 5 min at  150 g. The cell pellet was resuspended in 5-8 ml of saline, 
100 #c of radioactive chromium was added, and the mixture was then incubated for 1 hr at 
room temperature. At the end of the incubation period the cells were washed three times with 
40 ml of saline, counted, assayed for radioactivity, and finally resuspended in M  199 so as to 
provide 100 X  106 lymphocytes/ml. 
Deter~Mnation of Motility and Exclusion of Trypan Blue by  Untreated and Neuramlnidase- 
Treated Labeled Lymphocytey.---50 X  106 ~lCr-labeled lymphocytes in 0.5 ml M  199 were incu- 
bated in a 37°C water bath with either no enzyme or 12.5 units of neuraminidase for 15 min. 
The cells were then diluted to 2 ml with M  199 and centrifuged at 150 g for 5 min. For studies 
of cell motility, the cell pellet was resuspended in M  199 with 15% calf serum so as to provide 
5 X  10 ~ cells/ml. The cells were then observed for motility under phase-contrast microscopy 
at 37°C during a  3 hr period. For studies of exclusion of vital dye, the cell pellet was resus- 
pended in 0.5 ml saline and then incubated at 37°C.  Aliquots were removed at 0, 15, 30, and 
60 rain, mixed with an equal volume of 0.25% trypan blue in saline, and examined at a mag- 
nification of 100. 
Determination of  Agglutinability of  Untreated and  Neuraminidase-Treated 51Cr-Labeled 
Lymphocytes.--50 X  106  ~lCr-labeled  lymphocytes  in  0.5  ml  M  199  were incubated  with 
either no enzyme or 12.5 units of neuraminidase at 37°C for 15 min. The cells were then centri- 
fuged and resuspended in either autologous rat serum, calf serum, or M  199 so as to provide 
10  ~ lymphocytes/ml. The cell suspensions were then  incubated  at  37°C  and  samples were 
streaked on slides and examined for agglutination at  a  magnification of 100  at intervals be- 
tween 15 rain and 2 hr. The degree of agglutination was  recorded  as 0~t+,  each 1+  repre- 
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Determination of Changes in Electrophoretic Mobility of Heat-Killed and of Neuraminidase- 
Treated Lymphocytes.--The  eleetrophoretic mobility of untreated, heat-killed, and neuramini- 
dase-treated lymphocytes was determined in a rectangular type apparatus by the method of 
Angers and Rottino (15). "Untreated" lymphocytes were prepared for electrophoresis by incu- 
bating 50 X  106 washed lymphocytes in 0.5 ml saline or M  199 for 15 rain at 37°C. Heat-killed 
lymphocytes were prepared by incubating 50 X  106 washed lymphocytes in 0.5 ml saline for 
10 rain at 45°C. Neuraminidase-treated lymphocytes were prepared by incubating 50 X  10  e 
lymphocytes in 0.5 ml M  199 with 12.5 units of neuraminidase for 15 rain at 37°C. At the end 
of each incubation period,  5 ml of M  199 was added to each suspension, the samples were 
then centrifuged, and the cell pellet resuspended in 5 ml saline. Immediately before making 
the electrophoretic determination, the samples were centrifuged and the cell pellets resus- 
pended in Michaclis buffer at pH 7.0 so as to provide 2-4 X  106 cells/ml. No more than 30 
rain elapsed between the last saline wash and suspension of the cells in Michaefis buffer. All 
measurements of electrophoretic mobility were performed at 25°C.  In each suspension the 
mobility of 10 randomly selected lymphocytes was determined and the average value obtained. 
Determination of Rdease of Sialic  Acid from Lymphocytes by Neuraminidase or by Acid 
ttydrolysis.--Lymphocytes  were separated from lymph and the cell pellet was resnspended in 
water for 30 see to lyse the few red cells present. The suspension was then made isotonic with 
an appropriate volume of five times isotonic saline and the lymphocytes washed twice in iso- 
tonic saline. The samples were then centrifuged and resuspended in M  199 so as to provide 
500 X  106 cells in a final volume of 0.5 ml. Nenraminidase (50 units) was then added to sus- 
pensions and the samples incubated for 30 rain. After incubation, the cells were sedimented by 
centrifugation at 150 g for 5 rain and the supernatants were assayed for free sialic acid. Super- 
natants obtained from lymphocytes handled in the same manner but incubated without neu- 
raminidase were used for comparison. Total noniipid sialic acid content of lymphocytes was 
determined by suspending a  washed, red cell-free, lymphocyte cell pellet containing 500 X 
106 lymphocytes in 2 ml of 0.1 N H2SO4 • The suspension was then heated for 1 hr at 90°C. 
After centrifugation the supematants were extracted with two volumes of isoamyl alcohol and 
duplicate afiquots of the aqueous phase were assayed for free sialic by the thiobarbituric acid 
method of Warren (16). Optical densities were measured both at 532 and 549 m/~ to correct for 
absorbancy at 549 rapt not due to sialic acid. N-acetyl neuramln~c acid was used as a standard. 
Assay for Leakage of 51Cr  from Labded Lymphocytes.--Aliquots  containing 50 X  106  ~lCr- 
labeled lymphocytes were suspended in 0.5 ml M  199 and incubated at 37°C  with  either no 
enzyme or 25 units of neuramlnldase for 5-60 min. At the end of the incubation periods, the 
lymphocyte suspensions were centrifuged at 4°C for 5 rain at 150 g, and the amounts of radio- 
activity in the cell pellet and in the supernatant were assayed. For all radioactive  assays a 
Nuclear-Chicago (Des Plaines, Ill.) single sample deep well counter, model No. 0547,  was used. 
Experimental  Design for  Transfusion  of Lympkocytes into  Recipients.--50  X  106  61Cr- 
labeled lymphocytes in 0.5 nil M  199 were dispensed in separate tubes. Immediately after in- 
cubation at 37°C for 15 rain with or without neuraminidase, each cell suspension was  trans- 
fused into the tail vein of a rat lightly anesthetized with ether. Each injection took no longer 
than 30 see.  Variations in distribution of  radioactivity were  minimized by completing  all 
transfusions within 30 mill after the labeled lympliocytes had been washed and resuspended in 
M  199. Recipients were killed by cervical dislocation and various organs removed. The super- 
ficial and deep cervical nodes and the mesenteric nodes from each recipient were carefully dis- 
sected free of fat and pooled. The lymph nodes and other organs were weighed and assayed for 
radioactivity. Usually a total of 0.4-0.8 g nodal tissue was obtained from one recipient. The 
spleens usually weighed 0.4-1.2  g.  For this mixed lymphoid and retieuloendotlieliai organ, 
values are reported as cpm/organ since, from recipient to recipient of untreated lymphocytes, 
values more closely coincided by this measure than by comparing epm/unit of weight. 
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left hepatic lobes 3 hr after transfusion of labeled lymphocytes. By this method, approximately 
2/3 of the liver was removed (19). At 48 hr after the transfusion of cells, these partially hepa- 
tectomized recipients were sacrificed  and the organs removed and assayed for radioactivity. 
In another group of experiments, the main lymphatic duct of a recipient was cannulated 
24 hr prior to intravenous transfusion  of labeled lymphocytes. Recipients prepared  in  this 
manner were transfused intravenously with either neuraminidase-treated or untreated lympho- 
cytes  (200-300  X  106 labeled lymphocytes in 1.5 ml M  199, incubated for 15 min at 37°C 
with or without neuramlnldase). The concentration of neuraminidase was adjusted to provide 
12.5 units/50 X  106 cells. After transfusion, the recipient rats were returned to Bollman cages 
and lymph collected continuously from them for 72 hr. At intervals of 4-16 hr, the lymph was 
centrifuged and  the cell pellets and  supernatants  were assayed for radioactivity.  The per- 
centage of total injected radioactivity recovered in the cell pellet per hour for each collection 
period was calculated and the value plotted on a graph at the midpoint of the collection period. 
TABLE  I 
Rdea~e  of Radioactivity  from  51Cr-Labded Lymphocytes  after  Incubation  with 
and  without  Neuraminidase 
Time of incubation 
~n 
5 
15 
30 
6O 
cpm/ceg pellet 
268,531 
260,756 
259,358 
272,984 
Units of neursminidase 
None 
cpm/supernatant 
7,175 
8,136 
9,052 
12,514 
cpra/c~l #eUet 
262,078 
275,495 
260,496 
265,865 
25 
cpm/sup~natant 
7,784 
7,243 
10,014 
10,927 
Each sample contained 50 X  l0 s 51Cr-labeled lymphocytes in 0.5 ml M  199. 
RESULTS 
Condition of 51Cr-Labeled Lymphocytes  at the Time of Transfusion  into  Re- 
cipients.--Mter incubation for 15 min at 37°C with neuraminidase,  lympho- 
cytes  appeared  morphologically  intact  and  unagglutinated under  the  light 
microscope. When preparations of lymphocytes incubated with neuraminidase 
were  examined  by phase-contrast microscopy  at 37°C, 87-92 %  of the cells 
exhibited typical lymphocyte motility during the 3 hr observation period.  In 
the  populations incubated without neuraminidase,  88-93%  of the lympho- 
cytes were  motile.  Similarly,  no  difference was  found in  the percentage of 
lymphocytes excluding trypan blue;  95-98%  of the lymphocytes in both en- 
zyme-treated and untreated populations excluded the dye. The effect of the 
neuraminidase preparation on the release of radioactivity from labeled  cells is 
shown in Table I. The data indicate that there was no significant difference in 
the  amount of radioactivity associated  with untreated and neuraminidase- 
treated lymphocytes even after I hr of incubation. 
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incubated with neuraminidase were unagglutinated, possessed several charac- 
teristics of "viability," and retained the radioactive label as well as untreated 
lymphocytes. Evidence was obtained, however, that neuraminidase did alter 
the lymphocytes. When neuraminidase-treated lymphocytes were resuspended 
and incubated in undiluted calf serum for 2 hr at 37°C, some agglutination of 
the cells occurred (2-t-). When autologous serum was used as the suspending 
medium, minimal r if any, agglutination was found, and, using M  199, no agglu- 
tination was seen. Lymphocytes not exposed to neuramlnldase, but otherwise 
handled in the same manner,  remained unagglutinated when resuspended in 
TABLE II 
Eflext of Neuraminidase on the Distribution  of Radioactivity  in Tissues of Recipients 
of slCr-Labeled Lymphocytes 
Neura-  minidase 
uni#s 
0 
2.5 
5.0 
12.5 
25.0 
25.0" 
Lymph  J  Nodes 
~pm/500 rag 
18,720 
12,642 
7,890 
4,503 
4,743 
18,420 
Liver  Lung 
:pm/5oo rng 
917 
2,091 
2,826 
3,830 
3,675 
812 
cpm/or&an 
23,279 
47,675 
65,156 
104,263 
95,182 
25,089 
cpm/500  rag 
4,703 
3,841 
2,661 
1,178 
1,744 
3,823 
c~n/or$an 
13,168 
12,288 
9,631 
3,465 
8,857 
14,082 
I  Spleen 
c~m/organ 
30,294 
26,240 
26,859 
14,336 
11,574 
31,321 
Thymus  Kidney 
cpm/SO0  cl~m/500 
mg  rag 
90  30 
26  45 
2  50 
0  35 
0  43 
40  37 
Each recipient was transfused with 50 X 10  ° labeled lymphocytes containing 169,640 cpm 
after incubation with the indicated amount of neuraminidase at 37°C for 15 rain; recipients 
sacrificed 30 rain after transfusion. 
* Neuraminidase and  lymphocytes incubated separatdy and  injected separatdy into 
recipient. 
calf serum as well as in autologous serum or M  199. In addition to the altered 
agglutinability of neuraminidase-treated lymphocytes, it was found that  the 
electrophoretic mobility of the enzyme-treated cells was substantially reduced; 
by  the  method  used,  the  mean  electrophoretic mobility  of  neuraminidase- 
treated lymphocytes (for five separate  experiments)  was  1.09  -4-  0.05  t~/sec 
per v/cm compared to a mean value (for eight separate experiments) of 1.59 4- 
0.17 #/sec per v/cm for untreated lymphocytes. The electrophoretic mobility 
of lymphocytes killed by heat was essentially the same as untreated lympho= 
cytes; i.e., 1.54 -4- 0.16 #/sec per v/cm (mean for five separate experiments). 
Incubation of lymphocytes with neuraminidase caused the release of free sialic 
acid from the cells. 0.034 -4- 0.003 t~moles sialic acid were released from 500 X 
106 lymphocytes incubated for 30 min at 37°C with 50 units of neuraminidase 
(mean of four separate determinations). This value represented 27 %  of the 
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0.003/~moles sialic acid/500  ×  106 lymphocytes.) No free sialic acid was de- 
tected in supernatants of lymphocytes incubated without neuraminidase. 
The Effect of Neuraminidase on the Distribution of Radioactivity in Tissue of 
Recipients Sacrificed 30 Min after  Transfusion of 61Cr-Labeled Lymphocytes.-- 
The distribution of radioactivity in tissues of recipients transfused with neur- 
aminidase-treated lymphocytes differed greatly from that found in recipients 
of untreated lymphocytes. In recipients of 51Cr-labeled lymphocytes incubated 
without enzyme, there was a relatively high concentration of radioactivity in 
the lymph nodes and spleen and low concentration of label in the liver. How- 
ever, in recipients of enzyme-treated 5~Cr-labeled cells, much less radioactivity 
concentrated in the lymph nodes and spleen and substantially more in the liver. 
TABLE III 
Effect of Time of Incubation of Lymphocytes witk the Neuraminidase Preparation on 
Accumulation of Radioactivity "in Lymph Nodes and Liver 
Neuraminidase  Time  in vitro  Lymph nodes  Liver 
units 
0 
0 
12.5 
12.5 
12.5 
m~ 
5 
15 
5 
10 
15 
cpm/500 mg 
2,851 
2,400 
1,363 
1,252 
772 
cpm/500 rag 
330 
325 
1,059 
1,271 
1,282 
Each recipient received  50 X 10  e lymphocytes  containing  30,200 cpm; recipients sacrificed 
30 min after transfusion. 
These alterations in the distribution of radioactivity depended on the amount 
of enzyme added to the in vitro reaction mixture (Table II). A clear-cut effect 
was observed using as little as 2.5 units of neuraminidase and maximal effect 
occurred with  12.5  units.  In 25  similar experiments, a  50-75%  reduction in 
accumulation of radioactivity/unit weight of lymph node occurred using 12.5 
units  of the neuraminidase preparation.  In all  such  experiments, the fall in 
radioactivity in the lymph nodes and spleen was accompanied by a rise in the 
liver. The same alteration in the pattern of distribution of radioactivity was 
found when donors and recipients were members of the same highly inbred 
strain of rats. Also, the same effects were found when the Behringwerke neur- 
aminidase was used instead  of the neuraminidase preparation obtained from 
General Biochemicals. 
When neuraminidase and lymphocytes incubated without enzyme were in- 
jected separately into one recipient, the distribution of radioactivity was the 
same as that observed in rats receiving untreated labeled  lymphocytes alone 
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incubating lymphocytes with neuraminidase was due to the effect of the enzyme 
preparation on the transfused lymphocytes rather than on the recipient rats. 
The effect of varying the time of incubation of lymphocytes with the neur- 
aminidase preparation from 5-15 rain is shown in Table III. Using 12.5 units 
of neuraminidase, increasing the time of incubation in vitro increased the effect. 
However, the extent of the effect was not proportional to the time of incubation; 
a large proportion of the effect induced by incubating for 15 rain occurred after 
only 5 rain of incubation. 
Neuraminidase is largely destroyed by heat at 65°C of 10 min (20).  In four 
separate  experiments, ,when  the  neuraminidase preparation  was  exposed  to 
these conditions before incubation with lymphocytes, its ability to alter the 
accumulation of radioactivity  in lymph nodes and liver of recipients was essen- 
tially abolished. A representative experiment is shown in Table IV. 
TABLE IV 
Effect of Heated igeuramlnidase on Accumulal~on of Radioactivity in Lymph Nodes and Liver 
Neuramlnldase  Lymph nodes  Liver 
unlts  cpm/500 rag  cpm/500 rag 
0  11,630  751 
12.5  3,978  1,871 
12.5"  11,231  700 
Each recipient transfused with 50 X 106 lymphocytes  containing 126,656 cpm; animals 
sacrificed at 30 rain after transfusion. 
* Neuraminidase  heated at 65°C for 10 rain prior to incubation  with lymphocytes. 
Since it has been shown that the rdease of sialic acid from sialylactose by 
neuraminidase can be inhibited by addition of free sialic acid to the reaction 
mixture (21),  it was of interest to determine the effect of adding neutralized 
sialic acid to the lymphocyte-enzyme  mixture. The results of one of three similar 
experiments is shown in Table V and demonstrate that the effectiveness of the 
neuraminidase  preparation  in  altering  the  distribution  of  radioactivity  in 
recipients could be inhibited by adding sialic acid to the in vitro reaction mix- 
ture. This inhibition by sialic acid occurred using the Behringwerke neuramini- 
dase as well as the neuramlnidase obtained from General Biochemicals. Neu- 
tralized sialic acid did not itself substantially alter the distribution of radio- 
activity in recipients. 
The  DistributiOn  of  Radioactivity  in  Recipients  Sacrificed  1-48  Hr  After 
Transfusion.--,The  accumulation of radioactivity in the lymph nodes, spleen, 
liver, and lungs of recipients sacrificed at various intervals after transfusion 
of  untreated  or  neuraminidase-treated  allogeneic  lymphocytes is  shown  in 
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Recipients  of  Lymphocytes  Incubated  Without  Neuraminidase.--Recipients 
of untreated lymphocytes sacrificed at 1, 8, or 21 hr after transfusion, accumu- 
lated an average of 18 %, 26 %, and 37 %, respectively, of the total radioactivity 
injected per gram lymph node. In recipients sacrificed at either 28 or 48 hr after 
transfusion,  the average recovery per gram lymph node was 20%. The con- 
centration of radioactivity in the spleen was highest in the first few hours after 
transfusion. The liver contained a relatively low and constant percentage of the 
total radioactivity injected at each interval tested. The concentration of radio- 
activity in the lungs was greatest in recipients sacrificed soon after transfusion; 
at later intervals after transfusion, very little radioactivity was recovered in 
that organ. 
TABLE  V 
Alteration of Effect of Neuraminidase by Addition of Sialic Acid to the Incubation Mixture 
Neuraminidase 
un~s 
o 
o 
o 
12.5 
12.5 
12.5 
Sialic acid 
mg 
o 
0.5 
1.0 
0 
0.5 
1.0 
Lymph nodes 
cpm/500 mg 
3,590 
3,895 
3,650 
1,764 
3,473 
3,225 
Liver 
cpm/JOOmg 
318 
274 
322 
964 
410 
330 
Each recipient was transfused with 50 X  106 lymphocytes containing 65,095 cpm after 
incubation at 37°C for 5 min with the indicated amounts of neuraminidase and/or sialic acid; 
recipients were sacrificed at 30 min after transfusion. 
Sialic acid, 10 mg/ml saline, was neutralized to pI-I 6.8 with 1 N NaOH prior to use. 
Recipients  of L ymphocytes Incubated with Neuraminidase.--At early intervals 
after transfusion, a substantially lower concentration of radioactivity was found 
in  the  lymph  nodes  of  recipients  of  neuraminidase-treated  lymphocytes as 
compared with that found in recipients of untreated lymphocytes. At 1, 3, and 
8 hr after transfusion, only 6--10 % of the injected radioactivity was recovered 
per gram of lymph node. However, as the interval between the time of injection 
and the time of sacrifice increased, the percentage of recovery of radioactivity 
in the lymph nodes increased. Thus, at 28 and 48 hr after transfusion, the per- 
centage recovery of radioactivity in lymph nodes in recipients of neuramini- 
dase-treated cells was about equal to that obtained in recipients of untreated 
lymphocytes. The percentage recovery of radioactivity in the livers of these 
recipients also differed markedly from that found in recipients of untreated 
lymphocytes. Much greater concentrations of radioactivity were found in the 
livers of these animals at 1 to 8 hr after transfusion. However, at later intervals, 
the percentage of total radioactivity recovered in the livers fell markedly. At 
each interval tested,  less radioactivity was found in  the spleens of these re- JUDITH  J.  WOODRU-E]~ AlffD BERTRAM  M.  GESNER  559 
TABLE VI 
Effect  of Neuraminidase  on Distribution of Radioactivity in  Tissue of Recipients Sacrificed a~ 
Intervals of 1 to 48 Hr after Transfusion of 5XCr-Labeled Lymphocytes 
Exp. 1  Exp. 2  Exp. 3  Exp. 4  Exp. 5  Exp. 6 
Time*  Treatment of cells~ 
hr  Percentage recovery of total injected radioactivity per gram lyrapk node 
I 
1 
3 
8 
21 
28 
48 
24  6 
17  10 
28  7 
44  16 
18 
12 
24 
28 
8  12 
7 
6 
15  32 
25 
20 
8 
9  40,42 
20  20,16 
17 
19,10 
19,18 
13,20,21, 
24 
16  20,27  21,26 
Percentage recovery of tolal injected radioactivity per total spleen 
1 
3 
8 
21 
28 
48 
12 
28 
28 
18 
7  26 
12  39 
11  36 
18  24 
8  28 
10 
13 
15  16 
14 
17 
2O 
]16  15,25 
112  18,22 
17 
18,14 
13,12 
15,16,10,  11  13,10  10,9 
Percentage recovery of tOtal injected radioacti~it2~ per total liver 
1 
3 
8 
21 
28 
48 
12 
8 
9 
8 
56 
49 
49 
16 
11 
9 
11 
11 
61  10 
57 
54 
31  8 
9 
8 
29 
20 
18 
20 
12,16 
10,25 
39,43 
25,40 
7,8,6,8  18 
Percentage recover  of total injected radioactivity per total lung 
6,7  13,16 
1 
3 
8 
21 
28 
48 
8  17 
1  20 
2  13 
2  4 
6  6 
10 
9 
6  2 
3 
1.2 
2 
2 
0.6 
2,2 
2,0.6 
2,2 
2,4 
2,0.8,0.6 
0.6 
0.3  0.6 
0.6 
0.2 
0.2 
* Time (hr) recipients sacrificed after transfusion d  cells.  Each recipient was transfused 
with 50 X  106 lymphoeytes in 0.5 ml M  199. 
:~ O,  recipients  of  51Cr-labeled  lymphocytes  incubated  without  neuraminidase.  N,  re- 
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cipients as compared to recipients of untreated cells. The pattern of accumula- 
tion of radioactivity in the lungs of these animals was similar to that  observed 
in recipients of untreated  lymphocytes. 
When  syngeneic,  instead  of  allogeneic,  donors  and  recipients  were  used, 
similar results were obtained (Fig. 1). 
Recipients of Heat-Killed Labeled Lympkocytes.--Two  recipients  of  heat- 
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FIG.  1. Uptake of radioactivity in the lymph nodes and liver in recipients of 51Cr-labeled 
untreated or neuraminidase-treated or heat-killed lymphocytes or of free "ICr. 
For recipients of untreated and neuraminldase-treated allogeneic lymphocytes, each point 
represents the average value for animals in experiments shown in Table VI. Each point for 
recipients of syngeneic  lymphocytes, heat-kilied lymphocytes,  and  free Na~-SZCr-O4 is the 
average value for two animals. For lymph nodes, the values represent percentages per gram 
lymph node, whereas for liver the values represent percentages for the total liver. The weights 
of the livers in recipients ranged from 10-15 g. Each recipient of lymphocytes received 50 X 
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killed labeled lymphocytes were sacrificed 1, 24,  and 48 hr after transfusion. 
At 1 hr virtually no radioactivity accumulated in lymph nodes and an average 
of 55 %  of the total injected radioactivity was recovered in the liver. Unlike 
recipients of neuraminidase-treated cells, the concentration of radioactivity in 
lymph nodes did not rise in these recipients sacrificed at later intervals. Further- 
more, although the recovery of radioactivity in the liver did fall somewhat in 
animals sacrificed 24 and 48 hr after transfusion, the extent of the loss of label 
from this organ was less than that observed in recipients of neuraminidase- 
treated cells sacrificed 21 or more hr after transfusion (Fig. 1). 
TABLE VII 
Effect of Partial Hepatectomy 3 Hr after  Transfusion of Neuraminidase-Treated  or  Untreated 
Lymphocytes on the Concentration of Radioactivity in Lymph Nodes of Recipients 
Sacrif~ed  at 48 Hr 
Treatment of recipients 
None 
Partial hepatectomy 
Treatment of transfused  cells 
None 
12.5 units neuraminidase 
None 
12.5 units neuraminidase 
Lymph nodes 
Exp. 1  Exp. 2 
cpm/5OOmg 
2,784  2,747 
2,595  2,256 
3,532  2,924 
3,901  3,334 
1,089  ~1,428 
1,349  1,049 
Each recipient transfused with 50 X  10 ¢ lymphocytes containing, in Exp.  1, 26,825 cpm 
and, in Exp. 2, 28,012 cpm. 
Each value shown is that obtained in one recipient. 
Recipients of Free ~lCr.--Two recipients of free Na~51Cr04 were sacrificed at 
1, 24, 48 hr after injection. The pattern of distribution of radioactivity and the 
percentage of total injected radioactivity recovered in the tissues was unlike 
that found in any of the preceding groups. Essentially no radioactivity was 
recovered in lymph nodes and spleens at each interval tested. The liver con- 
tained about 10% of the injected dose 1 hr after transfusion, and this fell to 
about 5 % in recipients sacrificed at 24--48 hr (Fig. 1). 
Accumulation of Radioactivity in Lymph Nodes of Recipients Partially Hepa- 
tectomized after Transfusion of Neuraminidase-Treated or  Untreated Lympho- 
cytes.--In  recipients of neuraminidase-treated lymphocytes, the timing of the 
fall in percentage recovery of radioactivity in the liver coincided with the rise 
in percentage recovery in lymph nodes. To determine whether radioactivity 
initially found in the liver contributed to the late rise of radioactivity in lymph 562  NEUKAMINIDASE  AND  TRANSFUSED  LYMPHOCYTES 
nodes, recipients were partially hepatectomized 3 hr after transfusion of labeled 
cells. The animals were then sacrificed 48 hr after transfusion and the radio- 
activity in lymph nodes assayed.  As shown in Table VII, partially hepatec- 
tomized recipients of neuraminidase-treated lymphocytes  had less radioactivity 
in lymph nodes than was found in nonhepatectomized recipients  of enzyme- 
treated cells. Partial hepatectomy after transfusion of untreated lymphocytes 
did not substantially reduce the accumulation of label in lymph nodes. 
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FIG. 2. Recovery of labeled ]ymphocTtes from the main lymphatic  duct of recipients of 
~lCr-labeled untreated or neuraminldase-treated lymphocytes or of free SlCr. 
Recipients  of  labeled  lymphocytes  received  200-300 X  l0 s  lymphocytes  containing 
194,000-586,000 cpm. The recipient of free Na2-SlCr-O4 received 500,000 cpm SlCr and 300 X 
l0 s unlabeled cells in separate sequential injections. 
Recovery of Labeled Cells in the Lymph of Recipients o¢ Neuraminidase-Treated 
or  Untreated  Lymphocytes.--The  pattern  of recovery of labeled  cells in  the 
lymph of  animals  transfused  with  neuraminidase-treated lymphocytes was 
markedly different from, that found in recipients of untreated lymphocytes. As 
illustrated in Fig.  2,  the peak recovery of radioactivity associated  with cells 
occurred later in recipients transfused with neuraminidase-treated lymphocytes 
as compared  to that found in recipients  of untreated lymphocytes. A similar 
delay in the peak recovery of radioactivity from recipients  of neuraminidase- 
treated cells was observed  when either antologous  or allogeneic lymphocytes 
were transfused.  The time of the peak recovery of labeled cells in the lymph of JUDITH  J.  WOODRI2-FF  AND  BERTRAM  M.  GESNER  563 
recipients  of neuraminidase-treated  lymphocytes roughly coincided  with  the 
late rise in accumulation of radioactivity in lymph nodes of animals  transfused 
with enzyme-treated cells. Less of the total injected radioactivity was recovered 
from  recipients  of  neuraminidase-treated  cells  compared  with  recipients  of 
untreated ceils. However, when autologous cells were used, the total percentage 
of radioactivity recovered from recipients  of neuraminidase-treated  lympho- 
cytes more closely approximated  the total  recovered from recipients  of un- 
treated  lymphocytes; 22%  of the injected radioactivity was recovered asso- 
ciated with cells when enzyme-treated autologous lymphocytes were transfused 
compared to 29% in recipients of untreated  autologous lymphocytes. When 
free r~Cr and  unlabeled,  untreated  autologous lymphocytes were transfused 
separatdy, less than  1% of the total radioactivity injected was recovered in 
the cell pellets from lymph during the entire collection period. 
DISCUSSION 
These results demonstrate that the distribution of radioactivity in the tissues 
of recipients of 61Cr-labeled lymphocytes incubated with neuran~nidase differs 
from that found in redpients of untreated lymphocytes. It is likely that the 
distribution of radioactivity in these experiments, especially that recovered in 
the lymph nodes and lymph, largely reflects the fate of the donor lymphocytes. 
In  the case of untreated  lymphocytes, the distrihufion  of radioactivity gen- 
erally coincides with the distribution of transfused donor lymphocytes demon- 
strated by others using various isotopes assayed by radioautographic as well 
as by counting techniques (1-7). The distribution of radioactivity in recipients 
of neuraminidase-treated cells is also thought to reflect generally the distribu- 
tion  of transfused lymphocytes since there  was a  selective accumulation  of 
radioactivity in the lymph nodes of recipients of neuraminidase-treated  cells 
at 28 hr and even as late as 48 hr after transfusion. The most likely way by 
which  radioactivity could selectively accumulate in  lymph nodes under  the 
conditions of these experiments is by being associated with donor lymphocytes 
that enter the nodes. The failure to recover radioactivity in lymph nodes when 
free Na2~lCrO, or labeled heat-killed  lymphocytes were transfused  supports 
this view. Also, it has been found that 51Cr which has been incorporated into 
lymphocytes is  very inefficiently  reincorporated  into  other  lymphocytes or 
other cell types (22, 23). Furthermore,  in radioantographic  studies using un- 
treated  and  neuraminidase-treated  lymphocytes labeled  with  3H-adenosine, 
the distribution of labeled lymphocytes coincided with the distribution of 51Cr 
in these experiments. 1 
Our interpretation of these results is, therefore, that lymphocytes incubated 
with  the neuraminidase  preparation  circulate  differently than  do untreated 
1 Gesner, B. M., J. J. Woodruff,  and R. McCluskey.  Manuscript in preparation. 564  NEU1LAMINIDASE  AND  TRANSFUSED  LYMIPHOCYTES 
lymphocytes. The results imply that, at early intervals after transfusion, many 
neuraminidase-treated lymphocytes become trapped in the liver while there is 
a  reduction in accumulation of the ceils  in the lymph nodes and spleen. At 
later  intervals  after  transfusion,  at  least  some  neuraminidase-treated  cells 
emigrate from the liver, selectively accumulate in lymph nodes, and recirculate 
to the lymph. These effects occur when the relationship between donor and 
recipient is either allogeneic or syngeneic. And, they are due to the action of the 
enzyme preparation on the transfused lymphocytes rather than on the recipient 
animal since no changes in the distribution of radioactivity occurred in re- 
cipients when the enzyme preparation and labeled lymphocytes were transfused 
separately. It is likdy that the neuraminidase content of the enzyme prepara- 
tions was  responsible  for the  effects since:  (a)  two  different neuraminidase 
preparations with different degrees of purification yielded essentially the same 
results;  (b)  the ability of the enzyme preparation to produce the effects was 
abolished by heating the preparation at 65°C for 10 min before use; and (c) the 
effects were inhibited by addition on neutralized sialic acid  to  the in  vitro 
reaction mixture. 
The alterations in lymphocytes induced by neuraminidase which cause the 
cells to circulate abnormally are unknown. However, it is likely that the effect 
was mediated by the interaction between neuraminidase and sialic acid  com- 
ponents of the lymphocyte surface. Presumably,  changes in  the cell  surface 
and/or metabolism of the cell ensuing from this reaction led to the changes in 
the distribution of the cells. There is little doubt that the surfaces of the cells 
were altered since they agglutinated in sera which did not cause the agglutina- 
tion of untreated lymphocytes and since the electrophoretic mobility of the 
cells was reduced. The later finding indicates that neuraminidase reduced the 
charge  density of  the  lymphocyte surface  and  implies  that  sialic  acid  was 
cleaved from the peripheral zone of the cell  (11-14);  this view is further sup- 
ported by the finding that free sialic acid could be detected in the supernatants 
of intact lymphocytes incubated with neuraminidase. It is not likely that the 
effect is due to "killing" the cells since the evidence indicates that neuramini- 
dase-treated lymphocytes which initially become trapped in the liver subse- 
quently emigrate from this organ and selectively concentrate in lymph nodes. 
These latter processes do not occur when heat-killed lymphocytes are trans- 
fused. In addition to this evidence that the cells remain viable in vivo, it has 
been found that neuraminidase treatment does not abolish the ability of rat 
lymphocytes to  produce  lethal  graft-against-host reactions  when  transfused 
into X-irradiated mice given syngeneic bone marrow cells (24). 
The association between neuraminidase-treated cells and the liver appears 
to be rather selective since the liver was the only organ in which increased 
radioactivity was found. The finding that heat-killed cells (or remnants thereof) 
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electrophoretic  mobility indicated that the charge density at the cell surface 
does not necessarily  forecast the in vivo fate of these cells. Since  all of the 
transfusions were made via the tail vein, which communicates with the inferior 
vena cava, presumably all of the transfused cells passed through the lungs be- 
fore reaching the liver. Yet the accumulation of radioactivity in the lungs of 
recipients  of neuraminidase-treated lymphocytes was not increased.  In fact, 
when changes in the lung did occur, less radioactivity was often recovered in 
this organ in recipients  of neuraminidase-treated cells. One possible  explana- 
tion for the selective  association  of neuraminidase-treated lymphocytes with 
the liver is that changes induced in the cell surface by this enzyme (directly or 
indirectly) caused the lymphocytes  to specifically bind to structures in the liver. 
Conversely, regeneration  of a more normal lymphocyte surface may be neces- 
sary before these cells are released from the liver. 
One probable  cause for the reduced accumulation of neuraminidase-treated 
lymphocytes in lymphoid tissues was their rapid removal from the circulation 
in the liver.  The finding that selective  accumulation of radioactivity in the 
lymph nodes and spleen was not completely abolished with excessive amount 
of neuraminldase suggests that at least some neuraminidase-treated lympho- 
cytes which reach these sites at early intervals after transfusion are capable of 
entering into them. These observations,  however,  do not decide whether re- 
moval of the cells in the liver is the only cause for the decreased accumulation 
of the cells in these lymphoid tissues.  In order  to investigate this problem 
further,  several  attempts were made to compare  the distriISution  of radio- 
activity in recipients  which were totally hepatectomized and enterectomized 
before transfusion of neuraminldase-treated or untreated lymphocytes. In all 
of these attempts, the recipients were extremely ill, and most experiments were 
unsuccessful because animals died very soon after the procedure.  In only one 
experiment,  a hepatectomized recipient  of neuraminldase-treated lymphocytes 
and a comparable  recipient  of untreated cells survived for 30 rain after trans- 
fusion. In that study, the accumulation of radioactivity in the cervical nodes 
in the recipient  of enzyme-treated lymphocytes was reduced by 35 % and the 
radioactivity in the lungs was not increased  (cpm/unit of weight). This single 
experiment,  in very sick animals,  should of course be viewed with great cau- 
tion. It is, however,  consistent with the view that removal of neuraminidase- 
treated lymphocytes in the liver is not the entire explanation for the reduction 
in accumulation of the ceils in lymph nodes. It is apparent that the relationships 
between neuraminldase-treated cells and the lymph nodes and spleen remain 
to be clarified. 
The evidence that neuraminldase can alter the fate of lymphocytes suggests 
that sialic acid constituents of the cell surface play an important role in ensur- 
ing the normal fate and distribution of these cells in the body. The findings 
also imply that reactions involving surface  sialic acid can influence the dis- 566  NEURAMINIDASE  AND  TRANSFUSED  LYMPIIOCYTES 
tribution of lymphocytes without "killing"  the cells. Similar effects might be 
caused not only by neuraminldase but also by other enzymes which by their 
action  alter the integrity of surface sialic acid.  Perhaps such processes could 
account in part for previous, similar results obtained using a crude glycosidase 
preparation derived from Clostridium  perfringens  (8).  In those studies,  neur- 
aminidase present in the crude enzyme preparation might also have contributed 
to the effect. Since sialic acid is one of several saccharide constituents  of the 
cell surface,  the present findings are consistent with  the hypothesis that cell 
surface sugars play a physiological role in ensuring the normal distribution of 
these cells and might act as sites of cellular reactions which influence their fate 
and behavior in the body (25). 
SUM3~AR¥ 
Evidence has been obtained that incubation of rat lymphocytes with neur- 
aminidase,  prior  to  intravenous  transfusion  into  allogeneic  or  syngeneic  re- 
cipients, alters the distribution of the cells. Many enzyme-treated lymphocytes 
initially become trapped in  the liver,  and  there is a  decrease in the selective 
accumulation of these cells in the lymph nodes and spleen. Subsequently, many 
enzyme-altered ceils emigrate from the liver, concentrate in lymph nodes, and 
recirculate to the lymph. The results suggest that sialic acid constituents of the 
lymphocyte surface play a  critical role in ensuring the normal distribution  of 
these cells in the body. The findings also imply that reactions involving surface 
siallc acid can markedly alter the fate of lymphocytes without  "killing"  the 
cells. 
We would like to acknowledge  the help of Dr. Antonio Rottino and the expert technical as- 
sistance of Mrs. Sandra Teitelbaum. 
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